Individuals with high PLMs had significantly higher Fazekas and ARWMC total scores than those with a lower PLM index.

In addition, I think the recognition across all diseases where not everyone is going to be an expert in FA, and people can refer readily to tertiary care centers and even ordinary care centers that ...

At this point, there are several therapies which are coming along, a large trial called the ExRx trial, which included the nutraceutical, nicotinamide riboside has finished. The data are not yet ...

Lucknow: Doctors at Sanjay Gandhi Postgraduate Institute of Medical Sciences (SGPGIMS) treated successfully a young woman ...

After getting a green light from the European Commission, Biogen’s Skyclarys is the first approved medicine for the inherited neurological disease Friedreich’s ataxia (FA) in the EU.

From wetting the bed to acne, we have crunched the numbers on the success rate of every single disability claim. It comes ...